Sign in

CIK 0001528115 · Non-accelerated filer<br>Smaller reporting company

Annexon, Inc.

Sign in to watch
Ticker
ANNX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
275414423
Phone
(650) 822-5500
Business address
1400 SIERRA POINT PARKWAY, BLDG C, SUITE 200, BRISBANE, CA, 94005
Open-market buys, last 90 days
$99,829
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$99,829. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Love Douglas +$100K PRESIDENT AND CEO 1 filing
Date Insider Transaction Shares Price Value Owned after
2021-02-25 Love Douglas President & CEO Grant or award · Stock Option (Right to Buy) +325,000 325,000
2021-02-05 Carson William H. Director Grant or award · Stock Option (Right to Buy) +20,000 20,000
2020-07-28 Redmile Group, LLC 10% owner Conversion +1,596,222 1,596,222
2020-07-28 Redmile Group, LLC 10% owner Conversion · Series D Redeemable Convertible Preferred Stock −14,062,719 0
2020-07-28 Clarus Lifesciences III, L.P. 10% owner Conversion +643,208 643,208
2020-07-28 Clarus Lifesciences III, L.P. 10% owner Conversion +950,134 1,593,342
2020-07-28 Clarus Lifesciences III, L.P. 10% owner Conversion +697,860 2,291,202
2020-07-28 Clarus Lifesciences III, L.P. 10% owner Conversion +239,433 2,530,635
2020-07-28 Clarus Lifesciences III, L.P. 10% owner Purchase +200,000 $17.00 $3.4M 2,730,635
2020-07-28 Clarus Lifesciences III, L.P. 10% owner Conversion · Series A-1 Redeemable Convertible Preferred Stock −5,666,667 0
2020-07-28 Clarus Lifesciences III, L.P. 10% owner Conversion · Series B Redeemable Convertible Preferred Stock −8,370,685 0
2020-07-28 Clarus Lifesciences III, L.P. 10% owner Conversion · Series C Redeemable Convertible Preferred Stock −6,148,147 0
2020-07-28 Clarus Lifesciences III, L.P. 10% owner Conversion · Series D Redeemable Convertible Preferred Stock −2,109,407 0
2020-07-28 Lew Jennifer EVP & Chief Financial Officer Purchase +2,000 $17.00 $34K 2,000
2020-07-28 Satter Muneer A Director Conversion +1,754,978 1,754,978
2020-07-28 Satter Muneer A Director Purchase +200,000 $17.00 $3.4M 1,954,978
2020-07-28 Satter Muneer A Director Conversion · Series A-1 Preferred Stock −3,095,238 0
2020-07-28 Satter Muneer A Director Conversion · Series B Preferred Stock −4,016,573 0
2020-07-28 Satter Muneer A Director Conversion · Series C Preferred Stock −5,537,036 0
2020-07-28 Satter Muneer A Director Conversion · Series D Preferred Stock −2,812,543 0

Page 14 of 15 · 292 trades